Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus

To assess maternal serum and cord blood apelin-36 and nesfatin-1 concentrations in pregnant women with and without gestational diabetes mellitus (GDM). Thirty pregnant women with GDM and 30 gestational age matched healthy pregnant subjects participated to the study. Maternal serum and cord blood nes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine 2012-06, Vol.41 (3), p.424-429
Hauptverfasser: Aslan, Mehmet, Celik, Onder, Celik, Nilufer, Turkcuoglu, Ilgin, Yilmaz, Ercan, Karaer, Abdullah, Simsek, Yavuz, Celik, Ebru, Aydin, Suleyman
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 429
container_issue 3
container_start_page 424
container_title Endocrine
container_volume 41
creator Aslan, Mehmet
Celik, Onder
Celik, Nilufer
Turkcuoglu, Ilgin
Yilmaz, Ercan
Karaer, Abdullah
Simsek, Yavuz
Celik, Ebru
Aydin, Suleyman
description To assess maternal serum and cord blood apelin-36 and nesfatin-1 concentrations in pregnant women with and without gestational diabetes mellitus (GDM). Thirty pregnant women with GDM and 30 gestational age matched healthy pregnant subjects participated to the study. Maternal serum and cord blood nesfatin-1 and apelin-36 levels were measured with ELISA, at the time of birth. The relationships between maternal serum and cord blood nesfatin-1 and apelin-36 levels, anthropometric and metabolic parameters were also assessed. Maternal serum apelin-36 levels were found higher (13.5 ± 8.3 vs. 9.6 ± 5.9 ng/ml, P  = 0.001) and nesfatin-1 levels were found lower (5.5 ± 8.1 vs. 8.1 ± 23.9 ng/ml, P  = 0.001) in patients with GDM compared with control pregnant women. However, the cord blood apelin-36 levels (8.8 ± 4.3 and 8.2 ± 1.9 ng/ml, P  = 0.618) and nesfatin-1 levels (5.4 ± 4.0 and 6.2 ± 10.3 ng/ml, P  = 0.688) were similar in the GDM and control groups, respectively. Maternal serum apelin-36 and nesfatin-1 levels correlated positively with their respective cord blood levels. Maternal serum and cord blood apelin-36 levels correlated negatively with the gestational age and birth weight. Similarly maternal serum and cord blood nesfatin-1 levels correlated negatively with the gestational age, but there was no correlation with the birth weight. We did not find a correlation between maternal serum apelin-36 and nesfatin-1 levels, maternal age, BMI, fasting glucose, fasting insulin, and HOMA-IR. Also cord blood apelin-36 and nesfatin-1 levels did not correlate with the maternal age, BMI, HOMA-IR, cord blood glucose, and cord blood insulin levels. Our results indicate that apelin-36 concentrations increase and nesfatin-1 concentrations decrease in maternal serum of women with GDM.
doi_str_mv 10.1007/s12020-011-9577-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1011190063</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1011190063</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-559993f98ffa1405442aa650b507b0173048c58c75c20b9b03feea946d39cbca3</originalsourceid><addsrcrecordid>eNp9kLtOwzAUhi0EoqXwACzII4vh-JbEI6q4iUosILFZtuNUqdy4xAkSb4-rFEam48t3fv36ELqkcEMByttEGTAgQClRsixJdYTmVEqVXwCO85lLSQCqjxk6S2kDwBgrylM0yxO4KKo5elnGvsY2xFjjzqfGDG1HKDZdjc3Oh3zhBQ7-y4eE2w6vfRoyEjsTcN0a6wef8NaH0A5jOkcnjQnJXxzmAr0_3L8tn8jq9fF5ebcijgsxkFxQKd6oqmkMFSCFYMYUEqyE0gItOYjKycqV0jGwygJvvDdKFDVXzjrDF-h6yt318XPMjfS2TS6XMJ2PY9I0C6EKoOAZpRPq-phS7xu969ut6b8zpPcO9eRQ5xW9d6irvHN1iB_t1td_G7_SMsAmIOWvbu17vYljn5Wkf1J_AFi_es4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1011190063</pqid></control><display><type>article</type><title>Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Aslan, Mehmet ; Celik, Onder ; Celik, Nilufer ; Turkcuoglu, Ilgin ; Yilmaz, Ercan ; Karaer, Abdullah ; Simsek, Yavuz ; Celik, Ebru ; Aydin, Suleyman</creator><creatorcontrib>Aslan, Mehmet ; Celik, Onder ; Celik, Nilufer ; Turkcuoglu, Ilgin ; Yilmaz, Ercan ; Karaer, Abdullah ; Simsek, Yavuz ; Celik, Ebru ; Aydin, Suleyman</creatorcontrib><description>To assess maternal serum and cord blood apelin-36 and nesfatin-1 concentrations in pregnant women with and without gestational diabetes mellitus (GDM). Thirty pregnant women with GDM and 30 gestational age matched healthy pregnant subjects participated to the study. Maternal serum and cord blood nesfatin-1 and apelin-36 levels were measured with ELISA, at the time of birth. The relationships between maternal serum and cord blood nesfatin-1 and apelin-36 levels, anthropometric and metabolic parameters were also assessed. Maternal serum apelin-36 levels were found higher (13.5 ± 8.3 vs. 9.6 ± 5.9 ng/ml, P  = 0.001) and nesfatin-1 levels were found lower (5.5 ± 8.1 vs. 8.1 ± 23.9 ng/ml, P  = 0.001) in patients with GDM compared with control pregnant women. However, the cord blood apelin-36 levels (8.8 ± 4.3 and 8.2 ± 1.9 ng/ml, P  = 0.618) and nesfatin-1 levels (5.4 ± 4.0 and 6.2 ± 10.3 ng/ml, P  = 0.688) were similar in the GDM and control groups, respectively. Maternal serum apelin-36 and nesfatin-1 levels correlated positively with their respective cord blood levels. Maternal serum and cord blood apelin-36 levels correlated negatively with the gestational age and birth weight. Similarly maternal serum and cord blood nesfatin-1 levels correlated negatively with the gestational age, but there was no correlation with the birth weight. We did not find a correlation between maternal serum apelin-36 and nesfatin-1 levels, maternal age, BMI, fasting glucose, fasting insulin, and HOMA-IR. Also cord blood apelin-36 and nesfatin-1 levels did not correlate with the maternal age, BMI, HOMA-IR, cord blood glucose, and cord blood insulin levels. Our results indicate that apelin-36 concentrations increase and nesfatin-1 concentrations decrease in maternal serum of women with GDM.</description><identifier>ISSN: 1355-008X</identifier><identifier>EISSN: 1559-0100</identifier><identifier>DOI: 10.1007/s12020-011-9577-8</identifier><identifier>PMID: 22203468</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Adult ; Apelin ; Biomarkers - blood ; Birth Weight ; Calcium-Binding Proteins - blood ; Diabetes ; Diabetes, Gestational - blood ; DNA-Binding Proteins - blood ; Endocrinology ; Female ; Fetal Blood - metabolism ; Gestational Age ; Humanities and Social Sciences ; Humans ; Infant, Newborn ; Insulin - blood ; Intercellular Signaling Peptides and Proteins - blood ; Internal Medicine ; Male ; Medicine ; Medicine &amp; Public Health ; multidisciplinary ; Nerve Tissue Proteins - blood ; Original Article ; Pilot Projects ; Postpartum Period - blood ; Pregnancy ; Science</subject><ispartof>Endocrine, 2012-06, Vol.41 (3), p.424-429</ispartof><rights>Springer Science+Business Media, LLC 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-559993f98ffa1405442aa650b507b0173048c58c75c20b9b03feea946d39cbca3</citedby><cites>FETCH-LOGICAL-c344t-559993f98ffa1405442aa650b507b0173048c58c75c20b9b03feea946d39cbca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12020-011-9577-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12020-011-9577-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22203468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aslan, Mehmet</creatorcontrib><creatorcontrib>Celik, Onder</creatorcontrib><creatorcontrib>Celik, Nilufer</creatorcontrib><creatorcontrib>Turkcuoglu, Ilgin</creatorcontrib><creatorcontrib>Yilmaz, Ercan</creatorcontrib><creatorcontrib>Karaer, Abdullah</creatorcontrib><creatorcontrib>Simsek, Yavuz</creatorcontrib><creatorcontrib>Celik, Ebru</creatorcontrib><creatorcontrib>Aydin, Suleyman</creatorcontrib><title>Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus</title><title>Endocrine</title><addtitle>Endocrine</addtitle><addtitle>Endocrine</addtitle><description>To assess maternal serum and cord blood apelin-36 and nesfatin-1 concentrations in pregnant women with and without gestational diabetes mellitus (GDM). Thirty pregnant women with GDM and 30 gestational age matched healthy pregnant subjects participated to the study. Maternal serum and cord blood nesfatin-1 and apelin-36 levels were measured with ELISA, at the time of birth. The relationships between maternal serum and cord blood nesfatin-1 and apelin-36 levels, anthropometric and metabolic parameters were also assessed. Maternal serum apelin-36 levels were found higher (13.5 ± 8.3 vs. 9.6 ± 5.9 ng/ml, P  = 0.001) and nesfatin-1 levels were found lower (5.5 ± 8.1 vs. 8.1 ± 23.9 ng/ml, P  = 0.001) in patients with GDM compared with control pregnant women. However, the cord blood apelin-36 levels (8.8 ± 4.3 and 8.2 ± 1.9 ng/ml, P  = 0.618) and nesfatin-1 levels (5.4 ± 4.0 and 6.2 ± 10.3 ng/ml, P  = 0.688) were similar in the GDM and control groups, respectively. Maternal serum apelin-36 and nesfatin-1 levels correlated positively with their respective cord blood levels. Maternal serum and cord blood apelin-36 levels correlated negatively with the gestational age and birth weight. Similarly maternal serum and cord blood nesfatin-1 levels correlated negatively with the gestational age, but there was no correlation with the birth weight. We did not find a correlation between maternal serum apelin-36 and nesfatin-1 levels, maternal age, BMI, fasting glucose, fasting insulin, and HOMA-IR. Also cord blood apelin-36 and nesfatin-1 levels did not correlate with the maternal age, BMI, HOMA-IR, cord blood glucose, and cord blood insulin levels. Our results indicate that apelin-36 concentrations increase and nesfatin-1 concentrations decrease in maternal serum of women with GDM.</description><subject>Adult</subject><subject>Apelin</subject><subject>Biomarkers - blood</subject><subject>Birth Weight</subject><subject>Calcium-Binding Proteins - blood</subject><subject>Diabetes</subject><subject>Diabetes, Gestational - blood</subject><subject>DNA-Binding Proteins - blood</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Fetal Blood - metabolism</subject><subject>Gestational Age</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Insulin - blood</subject><subject>Intercellular Signaling Peptides and Proteins - blood</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>multidisciplinary</subject><subject>Nerve Tissue Proteins - blood</subject><subject>Original Article</subject><subject>Pilot Projects</subject><subject>Postpartum Period - blood</subject><subject>Pregnancy</subject><subject>Science</subject><issn>1355-008X</issn><issn>1559-0100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kLtOwzAUhi0EoqXwACzII4vh-JbEI6q4iUosILFZtuNUqdy4xAkSb4-rFEam48t3fv36ELqkcEMByttEGTAgQClRsixJdYTmVEqVXwCO85lLSQCqjxk6S2kDwBgrylM0yxO4KKo5elnGvsY2xFjjzqfGDG1HKDZdjc3Oh3zhBQ7-y4eE2w6vfRoyEjsTcN0a6wef8NaH0A5jOkcnjQnJXxzmAr0_3L8tn8jq9fF5ebcijgsxkFxQKd6oqmkMFSCFYMYUEqyE0gItOYjKycqV0jGwygJvvDdKFDVXzjrDF-h6yt318XPMjfS2TS6XMJ2PY9I0C6EKoOAZpRPq-phS7xu969ut6b8zpPcO9eRQ5xW9d6irvHN1iB_t1td_G7_SMsAmIOWvbu17vYljn5Wkf1J_AFi_es4</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Aslan, Mehmet</creator><creator>Celik, Onder</creator><creator>Celik, Nilufer</creator><creator>Turkcuoglu, Ilgin</creator><creator>Yilmaz, Ercan</creator><creator>Karaer, Abdullah</creator><creator>Simsek, Yavuz</creator><creator>Celik, Ebru</creator><creator>Aydin, Suleyman</creator><general>Springer US</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus</title><author>Aslan, Mehmet ; Celik, Onder ; Celik, Nilufer ; Turkcuoglu, Ilgin ; Yilmaz, Ercan ; Karaer, Abdullah ; Simsek, Yavuz ; Celik, Ebru ; Aydin, Suleyman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-559993f98ffa1405442aa650b507b0173048c58c75c20b9b03feea946d39cbca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Apelin</topic><topic>Biomarkers - blood</topic><topic>Birth Weight</topic><topic>Calcium-Binding Proteins - blood</topic><topic>Diabetes</topic><topic>Diabetes, Gestational - blood</topic><topic>DNA-Binding Proteins - blood</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Fetal Blood - metabolism</topic><topic>Gestational Age</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Insulin - blood</topic><topic>Intercellular Signaling Peptides and Proteins - blood</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>multidisciplinary</topic><topic>Nerve Tissue Proteins - blood</topic><topic>Original Article</topic><topic>Pilot Projects</topic><topic>Postpartum Period - blood</topic><topic>Pregnancy</topic><topic>Science</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aslan, Mehmet</creatorcontrib><creatorcontrib>Celik, Onder</creatorcontrib><creatorcontrib>Celik, Nilufer</creatorcontrib><creatorcontrib>Turkcuoglu, Ilgin</creatorcontrib><creatorcontrib>Yilmaz, Ercan</creatorcontrib><creatorcontrib>Karaer, Abdullah</creatorcontrib><creatorcontrib>Simsek, Yavuz</creatorcontrib><creatorcontrib>Celik, Ebru</creatorcontrib><creatorcontrib>Aydin, Suleyman</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aslan, Mehmet</au><au>Celik, Onder</au><au>Celik, Nilufer</au><au>Turkcuoglu, Ilgin</au><au>Yilmaz, Ercan</au><au>Karaer, Abdullah</au><au>Simsek, Yavuz</au><au>Celik, Ebru</au><au>Aydin, Suleyman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus</atitle><jtitle>Endocrine</jtitle><stitle>Endocrine</stitle><addtitle>Endocrine</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>41</volume><issue>3</issue><spage>424</spage><epage>429</epage><pages>424-429</pages><issn>1355-008X</issn><eissn>1559-0100</eissn><abstract>To assess maternal serum and cord blood apelin-36 and nesfatin-1 concentrations in pregnant women with and without gestational diabetes mellitus (GDM). Thirty pregnant women with GDM and 30 gestational age matched healthy pregnant subjects participated to the study. Maternal serum and cord blood nesfatin-1 and apelin-36 levels were measured with ELISA, at the time of birth. The relationships between maternal serum and cord blood nesfatin-1 and apelin-36 levels, anthropometric and metabolic parameters were also assessed. Maternal serum apelin-36 levels were found higher (13.5 ± 8.3 vs. 9.6 ± 5.9 ng/ml, P  = 0.001) and nesfatin-1 levels were found lower (5.5 ± 8.1 vs. 8.1 ± 23.9 ng/ml, P  = 0.001) in patients with GDM compared with control pregnant women. However, the cord blood apelin-36 levels (8.8 ± 4.3 and 8.2 ± 1.9 ng/ml, P  = 0.618) and nesfatin-1 levels (5.4 ± 4.0 and 6.2 ± 10.3 ng/ml, P  = 0.688) were similar in the GDM and control groups, respectively. Maternal serum apelin-36 and nesfatin-1 levels correlated positively with their respective cord blood levels. Maternal serum and cord blood apelin-36 levels correlated negatively with the gestational age and birth weight. Similarly maternal serum and cord blood nesfatin-1 levels correlated negatively with the gestational age, but there was no correlation with the birth weight. We did not find a correlation between maternal serum apelin-36 and nesfatin-1 levels, maternal age, BMI, fasting glucose, fasting insulin, and HOMA-IR. Also cord blood apelin-36 and nesfatin-1 levels did not correlate with the maternal age, BMI, HOMA-IR, cord blood glucose, and cord blood insulin levels. Our results indicate that apelin-36 concentrations increase and nesfatin-1 concentrations decrease in maternal serum of women with GDM.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>22203468</pmid><doi>10.1007/s12020-011-9577-8</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1355-008X
ispartof Endocrine, 2012-06, Vol.41 (3), p.424-429
issn 1355-008X
1559-0100
language eng
recordid cdi_proquest_miscellaneous_1011190063
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Apelin
Biomarkers - blood
Birth Weight
Calcium-Binding Proteins - blood
Diabetes
Diabetes, Gestational - blood
DNA-Binding Proteins - blood
Endocrinology
Female
Fetal Blood - metabolism
Gestational Age
Humanities and Social Sciences
Humans
Infant, Newborn
Insulin - blood
Intercellular Signaling Peptides and Proteins - blood
Internal Medicine
Male
Medicine
Medicine & Public Health
multidisciplinary
Nerve Tissue Proteins - blood
Original Article
Pilot Projects
Postpartum Period - blood
Pregnancy
Science
title Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T20%3A31%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cord%20blood%20nesfatin-1%20and%20apelin-36%20levels%20in%20gestational%20diabetes%20mellitus&rft.jtitle=Endocrine&rft.au=Aslan,%20Mehmet&rft.date=2012-06-01&rft.volume=41&rft.issue=3&rft.spage=424&rft.epage=429&rft.pages=424-429&rft.issn=1355-008X&rft.eissn=1559-0100&rft_id=info:doi/10.1007/s12020-011-9577-8&rft_dat=%3Cproquest_cross%3E1011190063%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1011190063&rft_id=info:pmid/22203468&rfr_iscdi=true